The best way to avoid this hazard is probably to reduce the insulin dosage temporarily before starting taurine therapy and subsequently readjust it as required, while keeping the patient under good surveillance and informing him about the possible risk, so that he may modify his carbohydrate intake as needed if he notices symptoms of incipient hypoglycaemia. This evidence concerns the gene INS and Hypoglycemia.